What is the appropriate evaluation and management for a persistent headache lasting three weeks?

Evaluation and Management of Persistent Headache Lasting Three Weeks

A persistent headache lasting three weeks requires immediate clinical evaluation to exclude secondary causes, followed by phenotype-based treatment if determined to be a primary headache disorder.

Initial Evaluation Priority

The first critical step is determining whether this represents a primary or secondary headache disorder. A 3-week continuous headache warrants heightened vigilance for serious underlying pathology.

Red Flags Requiring Urgent Investigation

Evaluate for these concerning features that suggest secondary headache 1:

• Abrupt onset ("thunderclap" quality)
• New onset after age 50 years
• Neurologic deficits on examination
• Progressive worsening pattern
• Awakens patient from sleep or worse with Valsalva maneuver
• Cancer history or immunosuppression
• Provocation by physical activity or postural changes

Essential History Components

Document these specific details 1:

• Onset characteristics: Sudden vs. gradual, any precipitating event
• Pain location: Unilateral vs. bilateral, frontal vs. occipital
• Pain quality: Throbbing, pressing, stabbing, squeezing
• Associated symptoms: Nausea, vomiting, photophobia, phonophobia, visual changes, aura
• Temporal pattern: Continuous vs. episodic, time of day variations
• Prior headache history and family history
• Medication use: Including over-the-counter analgesics (frequency critical for medication overuse headache)
• Trauma history within past 3 months

Neuroimaging Decision

Neuroimaging is indicated if:

• Abnormal neurologic examination findings
• Any red flag features present
• Atypical features not meeting strict migraine criteria 1

Neuroimaging is NOT routinely warranted with normal neurologic examination and typical primary headache features 1.

Management Based on Headache Type

If Migraine is Diagnosed

Acute Treatment Algorithm

First-line: NSAIDs 2, 3

• Aspirin 650-1000 mg
• Ibuprofen 400-800 mg
• Naproxen sodium 275-550 mg
• Note: Acetaminophen alone is NOT effective 2

Second-line (if NSAIDs fail after 2-3 attacks): Triptans 2, 3

• Sumatriptan (oral 25-100 mg, subcutaneous 6 mg, or intranasal)
• Rizatriptan 10 mg
• Zolmitriptan 2.5-5 mg
• Contraindications: Cardiovascular disease, uncontrolled hypertension, vasospastic conditions 1

Third-line: Gepants (CGRP antagonists) 3, 4

• Rimegepant or ubrogepant
• Safer in patients with cardiovascular risk factors
• Adverse effects: nausea, dry mouth (1-4% of patients)

If nausea/vomiting present: Use non-oral route + antiemetic 2

• Treat nausea aggressively even without vomiting
• Consider metoclopramide 10 mg or prochlorperazine 25 mg

Preventive Therapy Indications

Preventive therapy is indicated NOW given 3-week duration 2:

• ≥2 attacks per month causing ≥3 days disability per month
• Failure of acute treatments
• Use of abortive medication >2 times per week
• Uncommon migraine variants

First-line preventive agents 2, 5, 3:

• Beta-blockers: Propranolol 80-240 mg/day, metoprolol, atenolol, or bisoprolol
• Topiramate: 50-200 mg/day (titrate slowly)
• Candesartan: 16-32 mg/day
• Amitriptyline: 30-150 mg/day (especially if comorbid depression/insomnia)
• Divalproex sodium: 500-1500 mg/day (contraindicated in women of childbearing potential)

Second-line preventive agents 5:

• Flunarizine 10 mg/day (where available)

Third-line (if first/second-line fail): CGRP monoclonal antibodies 5, 3

• Erenumab, fremanezumab, galcanezumab, or eptinezumab
• Monthly or quarterly injections
• Generally reserved for treatment-resistant cases

Important: Preventive medications require 2-3 months for full effect 2. Start low, titrate slowly.

If Tension-Type Headache is Diagnosed

Acute treatment 3:

• Ibuprofen 400 mg
• Acetaminophen 1000 mg (effective for TTH, unlike migraine)

Preventive treatment (for chronic TTH) 3:

• Amitriptyline 25-75 mg at bedtime
• Physical therapy or aerobic exercise 3

Critical Pitfall: Medication Overuse Headache

Suspect medication overuse headache if:

• Using acute headache medications >2 days per week 6
• Headache present ≥15 days per month
• Pattern of increasing medication use with worsening headaches

Management:

• Abrupt withdrawal preferred for most agents 5
• Slow taper required for opioids, barbiturates, benzodiazepines (may need inpatient management) 6
• Initiate preventive therapy during withdrawal
• Expect temporary worsening before improvement

Non-Pharmacologic Interventions

Evidence-supported options 5, 3:

• Aerobic exercise: Regular structured program
• Biobehavioral therapy: Cognitive behavioral therapy, biofeedback
• Neuromodulation devices: Consider as adjunct
• Acupuncture: May provide benefit (though not superior to sham)

Limited/no evidence: Physical therapy alone, spinal manipulation, dietary elimination 5

Follow-Up Strategy

Immediate actions:

• Initiate headache diary tracking frequency, severity, duration, triggers, medication use, and response 2
• Schedule follow-up in 2-4 weeks to assess treatment response
• Set realistic expectations: improvement is gradual, not immediate

Ongoing management:

• Reassess diagnosis if treatment fails
• Verify medication adherence and proper dosing
• Address comorbidities: depression, anxiety, sleep disorders, chronic pain 6
• After 6-12 months of stability, consider tapering preventive therapy 2

When to Refer

Immediate neurology referral if:

• Red flags present with concerning imaging or examination
• Diagnostic uncertainty
• Chronic migraine (≥15 headache days/month for >3 months) 5
• Treatment failure of multiple preventive agents
• Consideration for CGRP antibodies or botulinum toxin

The key principle: Three weeks of continuous headache is NOT normal and demands action—either identifying and treating a secondary cause or aggressively managing a primary headache disorder with both acute and preventive strategies to prevent chronification and central sensitization 6.